Effect of V0251 in Acute Vertigo
NCT01583738 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2014-10-30
Summary
Assessment of efficacy and tolerance of a new anti-dizziness drug in acute vertigo.
Conditions
- Acute Vertigo
Interventions
- DRUG
-
V0251
single dose
- DRUG
-
single dose
Sponsors & Collaborators
-
Pierre Fabre Medicament
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
Countries
- Czechia
- France
- Germany
- Hungary
- Spain
Study Locations
More Related Trials
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
Ventilation Tube Insertion for Unilateral Menière's Disease
NCT04835688 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers
NCT05938517 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Lamotrigine to Treat Ménière's Disease
NCT02158585 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
SPI-1005 for the Treatment of Meniere's Disease
NCT04677972 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
NCT04218123 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis
NCT03399721 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
NCT01621256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
NCT02265393 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
NCT01270282 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
NCT00802425 ·Status: COMPLETED ·Phase: PHASE2
-
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
NCT06859788 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease
NCT01729767 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
NCT06001593 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of SENS 401 in Healthy Subjects
NCT03071003 ·Status: COMPLETED ·Phase: PHASE1
-
Latanoprost for the Treatment of Menière's Disease
NCT01973114 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02717442 ·Status: TERMINATED ·Phase: PHASE3
-
To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
NCT02213120 ·Status: COMPLETED
-
Acceleration of the Kinetics of Diffusion of Gadolinium in the Perilymphatic Structures of the Inner Ear.
NCT04949321 ·Status: UNKNOWN ·Phase: NA
-
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT05355610 ·Status: UNKNOWN ·Phase: NA